Oruka Therapeutics (ORKA) News Today $20.42 -1.78 (-8.02%) (As of 10:45 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Wedbush Reiterates "Outperform" Rating for Oruka Therapeutics (NASDAQ:ORKA)November 21 at 5:13 AM | americanbankingnews.comOruka Therapeutics gains approval for preferred stock conversionNovember 20 at 2:24 PM | investing.comPositive Outlook for Oruka Therapeutics Driven by Innovative Pipeline and Financial StabilityNovember 20 at 9:21 AM | markets.businessinsider.comWedbush Initiates a Buy Rating on Oruka Therapeutics (ORKA)November 19 at 4:21 PM | markets.businessinsider.comOruka Therapeutics’ Promising Long-Term Strategy and Advancements in Psoriasis Treatments Drive Buy RatingNovember 19 at 4:21 PM | markets.businessinsider.comWedbush Has Pessimistic Outlook of ORKA FY2024 EarningsNovember 19 at 1:53 AM | americanbankingnews.comLeerink Partnrs Brokers Lower Earnings Estimates for ORKANovember 18 at 2:55 AM | americanbankingnews.comOruka Therapeutics (NASDAQ:ORKA) and Biomerica (NASDAQ:BMRA) Financial ComparisonNovember 18 at 2:07 AM | americanbankingnews.comWhat is Leerink Partnrs' Forecast for ORKA FY2028 Earnings?November 17, 2024 | americanbankingnews.comHead to Head Analysis: Oruka Therapeutics (ORKA) and The CompetitionNovember 16, 2024 | americanbankingnews.comOruka Therapeutics, Inc.: Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 16, 2024 | finanznachrichten.deStrong Growth Potential for Oruka Therapeutics Driven by Robust Financials and Promising Drug PipelineNovember 15, 2024 | markets.businessinsider.comOruka Therapeutics (ORKA) & The Competition Financial ComparisonNovember 15, 2024 | americanbankingnews.comContrasting Oruka Therapeutics (ORKA) & The CompetitionNovember 15, 2024 | americanbankingnews.comAnalyzing FluoroPharma Medical (OTCMKTS:FPMI) & Oruka Therapeutics (NASDAQ:ORKA)November 15, 2024 | americanbankingnews.comHead to Head Review: Oruka Therapeutics (ORKA) vs. Its CompetitorsNovember 14, 2024 | americanbankingnews.comPositive Outlook for Oruka Therapeutics: Promising Developments with ORKA-001November 14, 2024 | markets.businessinsider.comOruka Therapeutics (ORKA) vs. Its Rivals Critical AnalysisNovember 14, 2024 | americanbankingnews.comOruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 13, 2024 | globenewswire.comFinancial Survey: Oruka Therapeutics (ORKA) versus The CompetitionNovember 12, 2024 | americanbankingnews.comOncoCyte (NASDAQ:OCX) and Oruka Therapeutics (NASDAQ:ORKA) Head to Head AnalysisNovember 12, 2024 | americanbankingnews.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Given Consensus Recommendation of "Buy" by BrokeragesNovember 12, 2024 | americanbankingnews.comContrasting Oruka Therapeutics (ORKA) & Its CompetitorsNovember 11, 2024 | americanbankingnews.comReviewing Oruka Therapeutics (ORKA) & Its RivalsNovember 11, 2024 | americanbankingnews.comOruka Therapeutics to Present at Multiple November Investor ConferencesNovember 4, 2024 | globenewswire.comPromising Prospects of ORKA-001 in the IL-23p19 Inhibitor Market: A Buy RecommendationNovember 1, 2024 | markets.businessinsider.comBuy Rating on Oruka Therapeutics for Innovative Psoriasis Treatments with Market-Leading PotentialOctober 11, 2024 | markets.businessinsider.comBuy Rating on Oruka Therapeutics Backed by ORKA-001’s Promising Preclinical Data and Dosing AdvantageSeptember 28, 2024 | markets.businessinsider.comBuy Rating on Oruka Therapeutics’ ORKA-001 for Extended Dosing and Market PotentialSeptember 26, 2024 | markets.businessinsider.comOruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology CongressSeptember 25, 2024 | globenewswire.comOruka Therapeutics Inc ORKASeptember 19, 2024 | morningstar.comOruka Therapeutics Poised for Outperformance with Innovative Psoriasis TreatmentsSeptember 18, 2024 | markets.businessinsider.comBuy Rating on Oruka Therapeutics: Promising Developments in Long-Acting Dermatological and Rheumatologic TreatmentsSeptember 16, 2024 | markets.businessinsider.comInnovative Antibody Engineering Positions Oruka Therapeutics for Market SuccessSeptember 16, 2024 | markets.businessinsider.comBiotech firm enters $200M agreementSeptember 12, 2024 | bizjournals.comOruka Therapeutics announces $200M private financingSeptember 12, 2024 | msn.comOruka Therapeutics Announces $200 Million Private PlacementSeptember 12, 2024 | tmcnet.comOruka Therapeutics, Inc. (ORKA)September 9, 2024 | ca.finance.yahoo.com Get Oruka Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ORKA and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin ORKA Media Mentions By Week ORKA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORKA News Sentiment▼-0.050.47▲Average Medical News Sentiment ORKA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORKA Articles This Week▼264▲ORKA Articles Average Week Get Oruka Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ORKA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VNRX News Today OCX News Today ICCC News Today AWH News Today TRIB News Today VRAX News Today CDIO News Today BMRA News Today MYMD News Today NAVB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORKA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oruka Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oruka Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ORKA Stock Alerts